PlainRecalls
FDA Drug Low Class III Terminated

Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2

Reported: May 25, 2022 Initiated: May 3, 2022 #D-0881-2022

Product Description

Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2

Reason for Recall

Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

Details

Recalling Firm
Apotex Corp.
Units Affected
2353 bottles
Distribution
Nationwide in the USA
Location
Weston, FL

Frequently Asked Questions

What product was recalled?
Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2. Recalled by Apotex Corp.. Units affected: 2353 bottles.
Why was this product recalled?
Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 25, 2022. Severity: Low. Recall number: D-0881-2022.